Business
Sarepta Therapeutics to Present at the RBC Capital Markets Global Healthcare Conference
CAMBRIDGE, Mass., May 13, 2026--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference at the InterContinental New York Barclay on Wednesday, May 20, at 8:30 a.m. ET.
About this update from Sarepta Therapeutics, Inc.
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":480,"height":426,"url":"https://media.zenfs.com/en/business-wire.com/845e77266a931abea8ff1b8d69a7570c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/EiQaehlmZB3f_ljO9.609g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTg1MjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/845e77266a931abea8ff1b8d69a7570c","width":480,"height":426},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/AhySFd4veE2ws3TYET9heQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTU2ODtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/845e77266a931abea8ff1b8d69a7570c","width":480,"height":426}},"lazy":false},{"type":"text","content":"CAMBRIDGE, Mass., May 13, 2026--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that senior management will participate in a fireside chat at the RBC Capital Markets Global Healthcare Conference at the InterContinental New York Barclay on Wednesday, May 20, at 8:30 a.m. ET.","length":361,"tagName":"p"},{"type":"text","content":"The presentations will be webcast live under the investor relations section of Sarepta’s website at https://investorrelations.sarepta.com/events-presentations and will be archived there following the presentation for 90 days. Please connect to Sarepta's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.","length":390,"tagName":"p"},{"type":"text","content":"About Sarepta Therapeutics","length":26,"tagName":"p"},{"type":"text","content":"Sarepta is on an urgent mission: engineer precision genetic medicine for rare diseases that devastate lives and cut futures short. We hold leadership positions in Duchenne muscular dystrophy (Duchenne) and are building a robust portfolio of programs across muscle, central nervous system, and cardiac diseases.","length":310,"tagName":"p"},{"type":"text","content":"Internet Posting of Information","length":31,"tagName":"p"},{"type":"text","content":"We routinely post information that may be important to investors in the 'For Investors' section of our website at www.sarepta.com. We encourage investors and potential investors to consult our website regularly for important in...